IDiyas

For the Inventor, By the Inventor

Wuppertal, Germany

Dieter Habich

USPTO Granted Patents = 31

Average Co-Inventor Count = 4.3

ph-index = 14

Forward Citations = 497(Granted Patents)


Location History:

  • Leverkusen, DE (1992)
  • Wuppertal, DE (1984 - 2000)

Company Filing History:

goldMedal30 out of 12,157 
 
Bayer Aktiengesellschaft
 patents
silverMedal1 out of 832,680 
Other
 patents

Years Active: 1984-2000

Loading Chart...
31 patents (USPTO):Explore Patents
1. 6069160 - Heteroatom-containing benzocyclopentane-oxazolidinones (2000-05-30),
2. 5922708 - Heteroaryl-oxazolidinones (1999-07-13),
3. 5869659 - Heteroatom-containing cyclopentanopyridyl-oxazolidinones (1999-02-09),
4. 5861413 - 2-oxo- and 2-thio-1,2-dihydroquinolinyl-oxazolidinones (1999-01-19),
5. 5843967 - 6-membered nitrogen-containing heteroaryl-oxazolidinones (1998-12-01),
6. 5827857 - Pyrido-fused thienyl- and furanyl-oxazolidinones (1998-10-27),
7. 5792765 - Substituted oxazolidinones (1998-08-11),
8. 5698574 - 5-membered heteroaryl-oxazolidinones (1997-12-16),
9. 5684023 - Benzofuranyl -and benzothienyloxazolidinones (1997-11-04),
10. 5646121 - Pseudopeptides with antiviral activity (1997-07-08),
11. 5633231 - Valine-containing pseudopeptides with antiviral activity (1997-05-27),
12. 5529998 - Benzoxazolyl- and benzothiazolyloxazolidinones (1996-06-25),
13. 5492918 - Use of substituted chromans, some of which are known, as medicaments, (1996-02-20),
14. 5492896 - Pseudopeptides having an antiviral action (1996-02-20),
15. 5480879 - Quinolonecarboxylic acids (1996-01-02),

Title: Innovations by Dieter Habich: A Pioneer in Medicinal Chemistry

Introduction

Dieter Habich, based in Wuppertal, Germany, is a notable inventor recognized for his significant contributions to medicinal chemistry. With an impressive portfolio of 31 patents, Habich has specialized in the development of compounds with potential therapeutic applications, particularly in the field of antibacterials.

Latest Patents

Among Habich's notable innovations are his latest patents:

1. **Heteroatom-containing benzocyclopentane-oxazolidinones** - This invention pertains to novel benzocyclopentaneoxazolidinones featuring heteroatoms. It addresses processes for their synthesis and outlines their application as medicaments, especially aimed at combating bacterial infections.

2. **Heteroaryl-oxazolidinones** - This patent introduces new heteroaryl-oxazolidinones, defined by a specific general formula. It includes details on their synthesis methods and emphasizes their utility as drugs, particularly in the treatment of bacterial ailments.

Career Highlights

Dieter Habich has had a fruitful career, exemplified by his tenure at Bayer Aktiengesellschaft, a leading company in the pharmaceutical sector. His work has significantly advanced the field of medicinal chemistry, highlighting his ability to translate complex chemical insights into practical applications in therapeutics.

Collaborations

Throughout his career, Habich has collaborated with prominent individuals in the field, including Rainer Endermann and Bernd Riedl. These partnerships have further propelled his innovative work, contributing to the successful development and patenting of his inventions.

Conclusion

Dieter Habich remains a vital figure in the realm of inventions, particularly in the development of antibacterial agents. His numerous patents and collaborations underscore his dedication to advancing medicinal chemistry, offering promising avenues for infection treatment and therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…